Skip to content
Baltimore News Journal – Lifestyle
Author:
Helus Pharma
Helus Pharma to Participate at the TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit
September 21, 2026
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
September 21, 2026
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
September 10, 2026
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
September 9, 2026
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
September 3, 2026
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
August 18, 2026
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
August 14, 2026
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
August 10, 2026
Helus Pharma Appoints Michael Halstead as Chief Executive Officer
August 3, 2026
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
July 21, 2026
1
2
Next Page
→